MIAMI MARLINS — Announced 2025 Coaching Staff ... MINNESOTA WILD — Recalled C Devin Shore from Iowa (AHL). NEW JERSEY DEVILS — Placed F Erik Haula on injured reserve. Recalled D Colton White from ...
TAMPA BAY RAYS — Agreed to terms with RHPs Jonathan Hernandez, Garrett Acton, Joey Gerber, Joey Krehbiel, LHP Jake Brentz, INF Coco Montes and OF Eloy Jiménez on minor league contracts.
Shares of Intra-Cellular, based in Bedminster, New-Jersey, jumped about 34% to $127.10 Monday. J&J’s stock edged up 1% to $143.45 ...
An Intra-University Transfer (IUT) allows current undergraduate students to change, add, or drop a major and degree program involving two different colleges/schools/programs within CU Boulder. The ...
Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...
The Johnson & Johnson headquarters in New Brunswick, New Jersey, on Feb. 8, 2024. Johnson & Johnson said Monday it will spend more than $14 billion to purchase Intra-Cellular Therapies.
J&J is paying $132 a share in cash for its fellow New Jersey-based company, a 60% premium on Intra-Cellular’s closing price on Friday. Bloomberg reported the companies were in talks on Sunday.
It took years for teams led by Stabler, Young and Manning to defeat their rivals in the postseason, something Josh Allen’s Bills — half of the intra-conference ... in New Jersey, this ...
Intra-Cellular Therapies ITCI signed a definitive agreement with pharma bigwig Johnson & Johnson JNJ. Per the terms, the pharma giant will acquire all outstanding shares of ITCI for $132 per share ...
Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...
Intra-Cellular Therapies (ITCI) shares soared 14.9% in the last trading session to close at $94.87. The move was backed by solid volume with far more shares changing hands than in a normal session.
Jan 12 (Reuters) - Drug maker Johnson & Johnson (JNJ.N), opens new tab is exploring a bid to acquire Intra-Cellular Therapies (ITCI.O), opens new tab, a biopharmaceutical company, Bloomberg News ...